Cheap Equities: U.S. Or Abroad?

Posted: Sep 07, 2010 14:49 PM by Sham Gad
Filed Under: Stock Analysis,Stocks
Tickers in this Article: AGU, BRFS, CAG, CAGC

The U.S. economy is expected to experience little or no growth in 2010 and possibly well into 2011. Nations like Brazil, India and China are expected to deliver solid growth results, absent some global economic shock. Since growth is directly tied to value creation for businesses, what's the choice between investing domestically versus abroad?

Get Free Stock Analysis By Email

IN PICTURES: 10 Tips For The Successful Long-Term Investor

The Balance Between Growth And Value

No matter how cheap a company's valuation appears to be, if it faces difficulty growing sales and profits, then no matter how low the share price, it's generally a sound idea to avoid it. An exception might be when the company's assets, unprofitable on their own, could fuel growth as part of another company. Then the assets may dictate value. Conversely, if a company shows signs of great growth ahead, it may ultimately appear valuable when at first blush it looked like an unattractively priced investment. Growth and value are two sides of the same coin that require one part art and one part analysis to find the happy medium between the two.

Too Rich?

An interesting article on Bloomberg illustrates the divergence between the U.S. markets and emerging market valuations and growth. Consider a company like Brasil Foods (NYSE: BRFS), a producer of meat, dairy products and processed foods in Brazil. It trades for a ridiculous 66 times earnings. But the company is expected to grow profits by more than 70% in 2011, and it sports a forward multiple of 22 times earnings. By comparison, ConAgra Foods (NYSE: CAG) trades for 14 times earnings, but it is expected to lift its profits by a single-digit percentage. In addition, ConAgra yields nearly 3.7 percent. But going forward, investors are saying that being a food company in Brazil offers a lot more growth opportunity than one in the U.S. due to expected economic growth going forward.

China Agritech (Nasdaq: CAGC) currently trades for 25 times earnings, but that earnings growth has been accelerating by over 100% a year. Indeed, its small size makes this happen, and it clearly won't last forever. But it's safe to assume that this nimble fertilizer company in China will likely grow profits at well above average rates over the next several years. By comparison, Agrium (NYSE: AGU) sports a P/E of 20 but stands no chance of growing at rates anywhere near CAGC due to its size and, to some extent, a cautious farmer mentality here in the U.S.

Preserving Capital

At the end of the day, any investment decision should have preservation of capital at the forefront of the thought process. In some cases, emerging market valuations are just too high despite the growth - and one small dose of bad news can lead to an exodus from the stock. On the other hand, in some situations future opportunities awaiting a company outside U.S. borders justify a premium. (For more, check out Does International Investing Really Offer Diversification?)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

 


By Sham Gad

Sham Gad is the Managing Partner of Gad Partners Fund's, value inspired investment partnerships modeled after the Buffett Partnerships of the 1950's. Previously, Gad ran the Gad Investment Group and delivered annualized returns of 22% from 2002 to 2005. Gad is also the author of "The Business of Value Investing" which will be out in the fall of 2009. Gad earned his MBA at the University of Georgia in May of 2007. Gad runs a value investing blog. He can also be reached by visiting the Gad Partners Funds site. When not writing or analyzing businesses, Gad enjoys hanging out with his wife Maggie, reading, golf, and yoga
Filed Under: Stock Analysis,Stocks
Rate this Article:  Your Rating:    Overall Rating: Vote Now!
Related Links
Marketplace
Related Links
Trading Center
New! The Financial Edge
Special Offers
Sponsored Links
add investopedia foot